BGBunge Global

$103.17+10% 1Y

Is the business good?

Mixed

The checks split: nothing decisive, though 3 of 9 health tests passed.

1 to watch, 1 neutral, 2 without data
Fundamental health (F-score)3 / 9SEC EDGAR · Dec 31, 2025

Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.

Where ROE comes from2% ROAderived

Efficiency-driven, thin margins turned over fast (the retail model). ROE 6% = margin × turnover × leverage.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbottom 5% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is BG?

Bunge Global keeps 1.1% of every revenue dollar as profit after everything, against 1.0% for the median Farm Products name.

1.1%

Net margin · Farm Products median 1.0% · 12 months to Q2 2026

Share count, year on year
+44%

Share count, year on year · shareholders own a smaller slice than a year ago

Gross margin
4.9%

Gross margin

Details›
Gross margin12 months to Q2 2026
4.9%
Net margin12 months to Q2 2026
1.1%
Free cash flow margin
−0.77%
Revenue, trailing twelve months
$91.8B
Free cash flow, trailing twelve months
−$711M
Net income, trailing twelve months
$1.01B

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.